Bio-Techne Corporation ( NASDAQ:TECH ) defied analyst predictions to release its quarterly results, which were ahead of...
Bio-Techne Corporation (NASDAQ:TECH) Q3 2024 Earnings Call Transcript May 1, 2024 Bio-Techne Corporation beats earnings expectations. Reported EPS is $0.48, expectations were $0.46. Bio-Techne Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, and welcome to the Bio-Techne […]
Despite mixed segment performance and macroeconomic pressures, TECH maintains a robust strategic outlook with key advancements in diagnostics and genomics.